--- title: Newsroom | Omics & Genetics description: Omics & Genetics | --- [![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/) - [Newsroom](https://news.lifesciencenewswire.com/newsroom) - [Back to the main site](https://lifesciencenewswire.com/) ![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1") # Newsroom #### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow") #### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg) ![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg) ### Choose a Category - [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture) - [AI (1)](https://news.lifesciencenewswire.com/newsroom/tag/ai) - [Analytical Chemistry (42)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry) - [Biomanufacturing (35)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing) - [biopharma (21)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma) - [Bioprocessing (16)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing) - [Biotechnology (251)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology) - [Cell Culture (10)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture) - [Clinical Diagnostics (36)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics) - [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research) - [Clinical Research & Trials (114)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) - [Computing & Technology (62)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it) - [Corporate, Finance & Investor (287)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) - [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19) - [Diagnostics & Hospital Laboratory (35)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory) - [Digital Pathology (1)](https://news.lifesciencenewswire.com/newsroom/tag/digital-pathology) - [Drug Discovery & Development (152)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) - [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment) - [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients) - [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage) - [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry) - [General Laboratory (58)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory) - [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science) - [Healthcare (135)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare) - [Hospital Management (7)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management) - [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science) - [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing) - [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science) - [Medical Devices & Technology (26)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology) - [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control) - [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging) - [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech) - [Omics & Genetics (87)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics) - [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology) - [Pharma (118)](https://news.lifesciencenewswire.com/newsroom/tag/pharma) - [Pharmacy (5)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy) - [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research) - [Veterinary (6)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary) - [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water) See all ### Subscribe to Email Updates Categories: [Omics & Genetics](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics), [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [Danish 3D cell culture company Celvivo secures USD 6.6 million in funding and appoints new CEO to lead next growth phase](https://news.lifesciencenewswire.com/newsroom/danish-3d-cell-culture-company-celvivo-secures-usd-6.6-million-in-funding-and-appoints-new-ceo-to-lead-next-growth-phase-1) August 27, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/danish-3d-cell-culture-company-celvivo-secures-usd-6.6-million-in-funding-and-appoints-new-ceo-to-lead-next-growth-phase-1) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/danish-3d-cell-culture-company-celvivo-secures-usd-6.6-million-in-funding-and-appoints-new-ceo-to-lead-next-growth-phase-1#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Aug 27, 2026, 12:30:00 PM - [Tweet](https://twitter.com/share) Categories: [Omics & Genetics](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics), [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [biopharma](https://news.lifesciencenewswire.com/newsroom/tag/biopharma) #### [Alithea Genomics Launches Early Access Program for MERCURIUS™ 1536 DRUG-seq, Bringing Transcriptomics to Compound Screening Scale](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale) June 16, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jun 16, 2026, 1:01:59 PM - [Tweet](https://twitter.com/share) Categories: [Omics & Genetics](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics), [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [Alithea Genomics and Revvity announce distribution agreement to expand access to MERCURIUS™ DRUG-seq solutions](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-and-revvity-announce-distribution-agreement-to-expand-access-to-mercuriustm-drug-seq-solutions) June 8, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-and-revvity-announce-distribution-agreement-to-expand-access-to-mercuriustm-drug-seq-solutions) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-and-revvity-announce-distribution-agreement-to-expand-access-to-mercuriustm-drug-seq-solutions#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jun 8, 2026, 12:00:00 PM - [Tweet](https://twitter.com/share) Categories: [Omics & Genetics](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics), [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [NGI becomes first certified core lab and service provider for Epigenica’s EpiFinder™ platforms](https://news.lifesciencenewswire.com/newsroom/ngi-becomes-first-certified-core-lab-and-service-provider-for-epigenicas-epifinder-platforms) May 19, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/ngi-becomes-first-certified-core-lab-and-service-provider-for-epigenicas-epifinder-platforms) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/ngi-becomes-first-certified-core-lab-and-service-provider-for-epigenicas-epifinder-platforms#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on May 19, 2026, 11:59:59 AM - [Tweet](https://twitter.com/share) Categories: [Omics & Genetics](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [Biognosys Group announces collaboration with The Michael J. Fox Foundation to advance Parkinson’s disease research through the development of improved biomarker assays](https://news.lifesciencenewswire.com/newsroom/biognosys-group-announces-collaboration-with-the-michael-j.-fox-foundation-to-advance-parkinsons-disease-research-through-the-development-of-improved-bi-1776076293763) April 14, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/biognosys-group-announces-collaboration-with-the-michael-j.-fox-foundation-to-advance-parkinsons-disease-research-through-the-development-of-improved-bi-1776076293763) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/biognosys-group-announces-collaboration-with-the-michael-j.-fox-foundation-to-advance-parkinsons-disease-research-through-the-development-of-improved-bi-1776076293763#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Apr 14, 2026, 12:00:02 PM - [Tweet](https://twitter.com/share) Categories: [Omics & Genetics](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics), [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [Plasmidsaurus accelerates RNA-Seq: New EU hub and Genovis partnership adds stability to speed, without the ice](https://news.lifesciencenewswire.com/newsroom/plasmidsaurus-accelerates-rna-seq-new-eu-hub-and-genovis-partnership-adds-stability-to-speed-without-the-ice) April 2, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/plasmidsaurus-accelerates-rna-seq-new-eu-hub-and-genovis-partnership-adds-stability-to-speed-without-the-ice) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/plasmidsaurus-accelerates-rna-seq-new-eu-hub-and-genovis-partnership-adds-stability-to-speed-without-the-ice#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Apr 2, 2026, 11:44:59 AM - [Tweet](https://twitter.com/share) Categories: [Omics & Genetics](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics), [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [Epigenica AB Expands presence in Japan through distribution agreement with PrimeTech](https://news.lifesciencenewswire.com/newsroom/epigenica-ab-expands-presence-in-japan-through-distribution-agreement-with-primetech) March 19, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/epigenica-ab-expands-presence-in-japan-through-distribution-agreement-with-primetech) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/epigenica-ab-expands-presence-in-japan-through-distribution-agreement-with-primetech#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Mar 19, 2026, 11:30:00 AM - [Tweet](https://twitter.com/share) Categories: [Omics & Genetics](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics), [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [University of Colorado grants license to Cirena for RNA-synthesis technology](https://news.lifesciencenewswire.com/newsroom/university-of-colorado-grants-license-to-cirena-for-rna-synthesis-technology) March 10, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/university-of-colorado-grants-license-to-cirena-for-rna-synthesis-technology) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/university-of-colorado-grants-license-to-cirena-for-rna-synthesis-technology#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Mar 10, 2026, 11:59:59 AM - [Tweet](https://twitter.com/share) Categories: [Omics & Genetics](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics), [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology) #### [Epigenica AB launches EpiFinder™ cNUC: The first platform to simultaneously profile multiple histone marks and DNA methylation directly from circulating nucleosomes in plasma and serum](https://news.lifesciencenewswire.com/newsroom/epigenica-ab-launches-epifinder-cnuc-the-first-platform-to-simultaneously-profile-multiple-histone-marks-and-dna-methylation-directly-from-circulating-1771597224314b) February 25, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/epigenica-ab-launches-epifinder-cnuc-the-first-platform-to-simultaneously-profile-multiple-histone-marks-and-dna-methylation-directly-from-circulating-1771597224314b) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/epigenica-ab-launches-epifinder-cnuc-the-first-platform-to-simultaneously-profile-multiple-histone-marks-and-dna-methylation-directly-from-circulating-1771597224314b#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Feb 25, 2026, 12:30:00 PM - [Tweet](https://twitter.com/share) [All posts](https://news.lifesciencenewswire.com/newsroom/all) [Next](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics/page/2) ##### Browse more news ## Recent releases #### [Ceryx Medical appoints Professor Zaheer Yousef OBE as Chief Medical Officer](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-appoints-professor-zaheer-yousef-obe-as-chief-medical-officer) September 21, 2026 Leading heart failure cardiologist and RSA-Pace principal investigator joins as the company prepares its next clinical study Ceryx Medical (Ceryx), th... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-appoints-professor-zaheer-yousef-obe-as-chief-medical-officer) #### [Qinecsa selected as technology partner for Africa’s new continent-wide medicines safety platform](https://news.lifesciencenewswire.com/newsroom/qinecsa-selected-as-technology-partner-for-africas-new-continent-wide-medicines-safety-platform) September 10, 2026 The global pharmacovigilance specialist will help drive one of Africa’s most comprehensive medicines safety initiatives. Qinecsa, the global pharmacov... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/qinecsa-selected-as-technology-partner-for-africas-new-continent-wide-medicines-safety-platform) #### [Sakura Finetek Europe launches Sakura Pathology Network](https://news.lifesciencenewswire.com/newsroom/sakura-finetek-europe-launches-sakura-pathology-network) September 10, 2026 A new initiative to connect and empower early-career pathologists across Europe Sakura Finetek Europe today announced the launch of the Sakura Patholo... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/sakura-finetek-europe-launches-sakura-pathology-network) ![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse") Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225  #### Useful information - [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/) - [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions) - [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)